We are calling for the development of a point-of-care TB test and working to increase access to treatment for drug resistant TB by supporting the introduction of promising new medicines and tackling supply problems of older drugs.
Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments
MSF stresses the urgent need to increase people’s access to these more effective treatments, by making them affordable and available. Read more
Tuberculosis: The Issues
MSF drug-resistant TB treatment in India
Narendra (name changed for anonymity) is one of only 2% of drug-resistant TB patients in need that have access to new TB drugs...